BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Algaba A, Linares PM, Encarnación Fernández-contreras M, Figuerola A, Calvet X, Guerra I, de Pousa I, Chaparro M, Gisbert JP, Bermejo F. The Effects of Infliximab or Adalimumab on Vascular Endothelial Growth Factor and Angiopoietin 1 Angiogenic Factor Levels in Inflammatory Bowel Disease: Serial Observations in 37 Patients. Inflammatory Bowel Diseases 2014;20:695-702. [DOI: 10.1097/mib.0000000000000004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Zhan H, Li H, Liu C, Cheng L, Yan S, Li Y. Association of Circulating Vascular Endothelial Growth Factor Levels With Autoimmune Diseases: A Systematic Review and Meta-Analysis. Front Immunol 2021;12:674343. [PMID: 34122433 DOI: 10.3389/fimmu.2021.674343] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Chen P, Zhou G, Lin J, Li L, Zeng Z, Chen M, Zhang S. Serum Biomarkers for Inflammatory Bowel Disease. Front Med (Lausanne). 2020;7:123. [PMID: 32391365 DOI: 10.3389/fmed.2020.00123] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]
3 Wang L, Wang S, Xue A, Shi J, Zheng C, Huang Y. Thalidomide Inhibits Angiogenesis via Downregulation of VEGF and Angiopoietin-2 in Crohn's Disease. Inflammation 2021;44:795-807. [PMID: 33206273 DOI: 10.1007/s10753-020-01378-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Gaetani E, Del Zompo F, Marcantoni M, Gatto I, Giarretta I, Porfidia A, Scaldaferri F, Laterza L, Lopetuso L, Gasbarrini A, Pola R. Microparticles Produced by Activated Platelets Carry a Potent and Functionally Active Angiogenic Signal in Subjects with Crohn's Disease. Int J Mol Sci 2018;19:E2921. [PMID: 30261608 DOI: 10.3390/ijms19102921] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
5 Matkar PN, Ariyagunarajah R, Leong-Poi H, Singh KK. Friends Turned Foes: Angiogenic Growth Factors beyond Angiogenesis. Biomolecules 2017;7:E74. [PMID: 28974056 DOI: 10.3390/biom7040074] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
6 Corcoran RM, MacDonagh P, O'Connell F, Morrissey ME, Dunne MR, Argue R, O'Sullivan J, Kevans D. Association Between Ex Vivo Human Ulcerative Colitis Explant Protein Secretion Profiles and Disease Behaviour. Dig Dis Sci 2022. [PMID: 35288829 DOI: 10.1007/s10620-022-07411-0] [Reference Citation Analysis]
7 Yin Y, Zhu ZX, Li Z, Chen YS, Zhu WM. Role of mesenteric component in Crohn’s disease: A friend or foe? World J Gastrointest Surg 2021; 13(12): 1536-1549 [DOI: 10.4240/wjgs.v13.i12.1536] [Reference Citation Analysis]
8 Casalino G, Querques G, Corvi F, Borrelli E, Triolo G, Ramirez GA, Bandello F. Choroidal neovascularization in a patient with Crohn's disease. Case Rep Ophthalmol 2014;5:249-54. [PMID: 25232338 DOI: 10.1159/000365881] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]